Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income 262 K66 K-678 K-613 K365 K543 K -383 K Non-Operating Income, Total 16.59 M-246 K-1.16 M-836 K3 00079 K -1.91 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 17.87 M173 K98 K-267 K86 K89 K 6 000 Unusual income/expense -1.27 M-419 K-1.25 M-569 K-83 K-10 K -1.92 M Pretax income 16.86 M-180 K-1.83 M-1.45 M368 K622 K -2.29 M Equity in earnings —————— — Taxes 4.18 M19 K-481 K-519 K146 K213 K -641 K Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 12.68 M-199 K-1.35 M-732 K222 K409 K -1.45 M Discontinued operations —————— — Net income 12.68 M-199 K-1.35 M-732 K222 K409 K -1.45 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 12.68 M-199 K-1.35 M-930 K222 K409 K -1.65 M Basic earnings per share (Basic EPS) 1.49-0.02-0.17-0.060.030.05 -0.15 Diluted earnings per share (Diluted EPS) 1.47-0.02-0.17-0.060.030.05 -0.15 Average basic shares outstanding 8.5 M8.49 M8.14 M8.23 M8.1 M8.15 M — Diluted shares outstanding 8.6 M8.49 M8.14 M8.26 M8.1 M8.15 M — EBITDA 18.31 M438 K-351 K-1.72 M737 K1.02 M -321 K EBIT 18.13 M239 K-580 K-1.97 M451 K632 K -1.47 M Cost of revenue 8.32 M7.2 M7.09 M10.17 M7.66 M6.35 M 31.27 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 181 K199 K229 K249 K286 K385 K 1.15 M